Related Experiment Videos
Mammary stem cells, self-renewal pathways, and carcinogenesis
Suling Liu1, Gabriela Dontu, Max S Wicha
1Comprehensive Cancer Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. sulingl@med.umich.edu
Breast Cancer Research : BCR
|July 1, 2005
Summary
Mammary gland stem cells, regulated by key pathways, may drive breast cancer when self-renewal is deregulated. Targeting these pathways offers a novel therapeutic strategy for breast cancer treatment.
Area of Science:
- * Molecular and Cellular Biology
- * Oncology
- * Developmental Biology
Background:
- * Mammary gland epithelial components originate from stem cells capable of self-renewal and differentiation.
- * Stem cell self-renewal is orchestrated by signaling pathways like Hedgehog, Notch, and Wnt, and the transcription factor Bmi-1 (B lymphoma Mo-MLV insertion region 1).
Purpose of the Study:
- * To review the existence and self-renewal regulation of mammary gland stem cells.
- * To explore the role of stem cell self-renewal deregulation in mammary carcinogenesis.
- * To propose targeting stem cell self-renewal pathways as a novel breast cancer therapy.
Main Methods:
- * Literature review of existing data on mammary gland stem cells and their regulatory pathways.
- * Analysis of evidence linking stem cell self-renewal to mammary gland development and cancer.
- * Conceptualization of therapeutic strategies based on pathway inhibition.
Main Results:
- * Evidence supports the existence of stem cells within the mammary gland.
- * Specific signaling pathways and transcription factors critically regulate stem cell self-renewal.
- * Deregulated self-renewal of mammary stem cells/progenitors is implicated as a key event in breast cancer development.
Conclusions:
- * Mammary gland stem cell self-renewal is a crucial process in normal development and disease.
- * Aberrant regulation of these pathways may initiate mammary carcinogenesis.
- * Targeting stem cell self-renewal pathways presents a promising avenue for innovative breast cancer treatments, especially for therapy-resistant tumors.